Longevity/Biotech Funding

Sector profile · 1 tracked rounds · $435 million tracked capital

Capvizr tracks Longevity/Biotech funding activity across newly funded companies, lead investors, hiring signals, and market narratives.

Top company NewLimitLargest round $435 million1 deals

Recent Longevity/Biotech rounds

NewLimit · $435 million · Series C · June 23, 2026

Market context

Longevity/Biotech deal flow is monitored for capital concentration, mega-rounds, and hiring expansion.

Open Longevity/Biotech in the interactive Capvizr dashboard →

Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime